Price $39.75 |
Market Cap
55.63B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
3.9
|
P/S
5.31
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
39.4
|
Op. Cash Flow
1.84M
|
FCF
0.9
|
|
Op. Margin
14.90%
|
Net Margin
46.30%
|
ROE
40.20%
|
ROI
6.00%
|
|
ROA
16.80%
|
EPS Growth
159.70%
|
Current Ratio
1.0
|
Debt/Equity
61.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Cumberland Pharmaceuticals, In (CPIX) | $3.38 | - | - | 48.8M | Strong Buy |
| Daxor Corporation (DXR) | $16.64 | - | - | 69.3M | Strong Buy |
| Advanz Pharma Corp Ltd (CXRXF) | $4.02 | - | - | 159M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $11.57 | - | - | 12.39B | Strong Buy |
| Community Health Systems Inc (CYH) | $4.51 | - | - | 589.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
